139 related articles for article (PubMed ID: 31744780)
1. Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification.
Peng K; Li Y; Bai Y; Jiang T; Sun H; Zhu Q; Xu Y
Bioorg Med Chem; 2020 Jan; 28(1):115183. PubMed ID: 31744780
[TBL] [Abstract][Full Text] [Related]
2. Architecture and hydration of the arginine-binding site of neuropilin-1.
Mota F; Fotinou C; Rana RR; Chan AWE; Yelland T; Arooz MT; O'Leary AP; Hutton J; Frankel P; Zachary I; Selwood D; Djordjevic S
FEBS J; 2018 Apr; 285(7):1290-1304. PubMed ID: 29430837
[TBL] [Abstract][Full Text] [Related]
3. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
[TBL] [Abstract][Full Text] [Related]
5. Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking.
Vique-Sánchez JL
Bioorg Med Chem; 2021 Mar; 33():116040. PubMed ID: 33515918
[TBL] [Abstract][Full Text] [Related]
6. Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells.
Powell J; Mota F; Steadman D; Soudy C; Miyauchi JT; Crosby S; Jarvis A; Reisinger T; Winfield N; Evans G; Finniear A; Yelland T; Chou YT; Chan AWE; O'Leary A; Cheng L; Liu D; Fotinou C; Milagre C; Martin JF; Jia H; Frankel P; Djordjevic S; Tsirka SE; Zachary IC; Selwood DL
J Med Chem; 2018 May; 61(9):4135-4154. PubMed ID: 29648813
[TBL] [Abstract][Full Text] [Related]
7. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction.
Jarvis A; Allerston CK; Jia H; Herzog B; Garza-Garcia A; Winfield N; Ellard K; Aqil R; Lynch R; Chapman C; Hartzoulakis B; Nally J; Stewart M; Cheng L; Menon M; Tickner M; Djordjevic S; Driscoll PC; Zachary I; Selwood DL
J Med Chem; 2010 Mar; 53(5):2215-26. PubMed ID: 20151671
[TBL] [Abstract][Full Text] [Related]
8. Integrating pharmacophore mapping, virtual screening, density functional theory, molecular simulation towards the discovery of novel apolipoprotein (apoE ε4) inhibitors.
Johari S; Sharma A; Sinha S; Das A
Comput Biol Chem; 2019 Apr; 79():83-90. PubMed ID: 30743160
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
10. N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity.
Jia H; Aqil R; Cheng L; Chapman C; Shaikh S; Jarvis A; Chan AW; Hartzoulakis B; Evans IM; Frolov A; Martin J; Frankel P; Djordevic S; Zachary IC; Selwood DL
Chembiochem; 2014 May; 15(8):1161-70. PubMed ID: 24771685
[TBL] [Abstract][Full Text] [Related]
11. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting.
Pan Q; Chathery Y; Wu Y; Rathore N; Tong RK; Peale F; Bagri A; Tessier-Lavigne M; Koch AW; Watts RJ
J Biol Chem; 2007 Aug; 282(33):24049-56. PubMed ID: 17575273
[TBL] [Abstract][Full Text] [Related]
12. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
Zaka M; Abbasi BH; Durdagi S
J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
Aarthy M; Singh SK
Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics to enhance structure-based virtual screening on cathepsin B.
Ogrizek M; Turk S; Lešnik S; Sosič I; Hodošček M; Mirković B; Kos J; Janežič D; Gobec S; Konc J
J Comput Aided Mol Des; 2015 Aug; 29(8):707-12. PubMed ID: 25947277
[TBL] [Abstract][Full Text] [Related]
15. VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.
Mehta V; Fields L; Evans IM; Yamaji M; Pellet-Many C; Jones T; Mahmoud M; Zachary I
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1845-1858. PubMed ID: 29880492
[TBL] [Abstract][Full Text] [Related]
16. Discovery of protein-protein binding disruptors using multi-component condensations small molecules.
Bedjeguelal K; Bienaymé H; Dumoulin A; Poigny S; Schmitt P; Tam E
Bioorg Med Chem Lett; 2006 Aug; 16(15):3998-4001. PubMed ID: 16765048
[TBL] [Abstract][Full Text] [Related]
17. Structure-based discovery of novel small molecule inhibitors of platelet-derived growth factor-B.
Zarei O; Sarri N; Dastmalchi S; Zokai F; Papadopoulos N; Lennartsson J; Heldin CH; Hamzeh-Mivehroud M
Bioorg Chem; 2020 Jan; 94():103374. PubMed ID: 31699389
[TBL] [Abstract][Full Text] [Related]
18. A combinatorial approach of structure-based virtual screening and molecular dynamics simulation towards the discovery of a highly selective inhibitor for VP9 coat protein of Banna virus.
Moitra P
Bioorg Chem; 2019 May; 86():15-27. PubMed ID: 30684859
[TBL] [Abstract][Full Text] [Related]
19. Microplate-based screening for small molecule inhibitors of neuropilin-2/vascular endothelial growth factor-C interactions.
Parker MW; Vander Kooi CW
Anal Biochem; 2014 May; 453():4-6. PubMed ID: 24583243
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
Baek DS; Kim JH; Kim YJ; Kim YS
Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
